HPV Test Approval Standards Laid Out In FDA Draft Guidance
This article was originally published in Clinica
Executive Summary
FDA issued draft guidance on clinical study designs to support PMAs for diagnostics that detect, or detect and differentiate, human papillomaviruses linked to cervical cancer.